Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study.
Giudice V, Pagliano P, Vatrella A, Masullo A, Poto S, Polverino BM, Gammaldi R, Maglio A, Sellitto C, Vitale C, Serio B, Cuffa B, Borrelli A, Vecchione C, Filippelli A, Selleri C.
Giudice V, et al. Among authors: vitale c.
Front Pharmacol. 2020 Jun 5;11:857. doi: 10.3389/fphar.2020.00857. eCollection 2020.
Front Pharmacol. 2020.
PMID: 32581810
Free PMC article.